5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 2.06▼ | 2.07▼ | 2.07▼ | 2.15▼ | 2.16▼ |
MA10 | 2.07▼ | 2.07▼ | 2.07▼ | 2.14▼ | 2.14▼ |
MA20 | 2.07▼ | 2.09▼ | 2.12▼ | 2.15▼ | 2.06▲ |
MA50 | 2.10▼ | 2.15▼ | 2.12▼ | 2.13▼ | 2.11▼ |
MA100 | 2.15▼ | 2.11▼ | 2.14▼ | 2.04▲ | 1.96▲ |
MA200 | 2.12▼ | 2.14▼ | 2.14▼ | 2.15▼ | 5.88▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.001▲ | 0.001▲ | -0.007▼ | -0.008▼ | 0.013▲ |
RSI | 36.245▼ | 33.453▼ | 35.313▼ | 44.606▼ | 48.962▼ |
STOCH | 9.722▼ | 62.593 | 18.979▼ | 61.111 | 60.299 |
WILL %R | -100.000▼ | -88.889▼ | -96.296▼ | -69.697 | -53.545 |
CCI | -87.500 | -62.348 | -70.340 | -93.281 | -11.326 |
Thursday, August 07, 2025 04:37 AM
Key Points Revenue (GAAP) exceeded analyst expectations by 9.3%, reaching $4.1 million, up 32% from the prior year period. Operating expenses fell 21%, narrowing the net loss compared to Q2 2024.
|
Thursday, August 07, 2025 12:17 AM
Discover Seer, Inc.'s Q2 2025 earnings insights, featuring 32% revenue growth, the Proteograph ONE launch, and a groundbreaking 20,000-sample study.
|
Wednesday, August 06, 2025 03:15 PM
Achieved revenue of $4.1 million for the second quarter of 2025 Launched new high-throughput Proteograph ONE assay and SP200 automation instrument, enabling previously unattainable scale and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 2.06 | 2.10 | 2.05 | 2.07 | 93,753 |
14/08/25 | 2.17 | 2.17 | 2.07 | 2.08 | 134,299 |
13/08/25 | 2.20 | 2.20 | 2.155 | 2.17 | 85,595 |
12/08/25 | 2.20 | 2.23 | 2.19 | 2.20 | 61,372 |
11/08/25 | 2.19 | 2.225 | 2.175 | 2.21 | 122,993 |
08/08/25 | 2.02 | 2.30 | 1.97 | 2.30 | 692,887 |
07/08/25 | 2.07 | 2.07 | 2.0046 | 2.01 | 180,409 |
06/08/25 | 2.11 | 2.11 | 2.05 | 2.06 | 139,274 |
05/08/25 | 2.13 | 2.14 | 2.105 | 2.12 | 78,637 |
04/08/25 | 2.13 | 2.135 | 2.105 | 2.13 | 34,738 |
|
|
||||
|
|
||||
|
|